134 related articles for article (PubMed ID: 16266382)
1. Quality of asthma care: results from a community pharmacy based survey.
Laforest L; Van Ganse E; Devouassoux G; Chretin S; Bauguil G; Pacheco Y; Chamba G
Allergy; 2005 Dec; 60(12):1505-10. PubMed ID: 16266382
[TBL] [Abstract][Full Text] [Related]
2. Asthmatic patients' poor awareness of inadequate disease control: a pharmacy-based survey.
Laforest L; Van Ganse E; Devouassoux G; Osman LM; Brice K; Massol J; Bauguil G; Chamba G
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):146-52. PubMed ID: 17304881
[TBL] [Abstract][Full Text] [Related]
3. Influence of patients' characteristics and disease management on asthma control.
Laforest L; Van Ganse E; Devouassoux G; Bousquet J; Chretin S; Bauguil G; Pacheco Y; Chamba G
J Allergy Clin Immunol; 2006 Jun; 117(6):1404-10. PubMed ID: 16751004
[TBL] [Abstract][Full Text] [Related]
4. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
5. Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control.
Armour CL; Lemay K; Saini B; Reddel HK; Bosnic-Anticevich SZ; Smith LD; Burton D; Song YJ; Alles MC; Stewart K; Emmerton L; Krass I
J Asthma; 2011 Nov; 48(9):914-22. PubMed ID: 21942306
[TBL] [Abstract][Full Text] [Related]
6. Dispensing of antibiotics, antitussives and mucolytics to asthma patients: a pharmacy-based observational survey.
Laforest L; Van Ganse E; Devouassoux G; El Hasnaoui A; Osman LM; Bauguil G; Chamba G
Respir Med; 2008 Jan; 102(1):57-63. PubMed ID: 17913486
[TBL] [Abstract][Full Text] [Related]
7. Survey on the impact of comorbid allergic rhinitis in patients with asthma.
Valovirta E; Pawankar R
BMC Pulm Med; 2006 Nov; 6 Suppl 1(Suppl 1):S3. PubMed ID: 17140421
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey.
Laforest L; Van Ganse E; Devouassoux G; Osman LM; Pison C; El Hasnaoui A; Bauguil G; Chamba G
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):230-6. PubMed ID: 18426142
[TBL] [Abstract][Full Text] [Related]
9. Pharmacy-specific quality indicators for asthma therapy.
Winterstein AG; Hartzema AG
Res Social Adm Pharm; 2005 Sep; 1(3):430-45. PubMed ID: 17138488
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported adverse events under asthma therapy: a community pharmacy-based survey.
Laforest L; Van Ganse E; Devouassoux G; Osman LM; Bauguil G; Chamba G
Clin Pharmacol Ther; 2007 Aug; 82(2):167-72. PubMed ID: 17495876
[TBL] [Abstract][Full Text] [Related]
11. Adherence to anti-inflammatory treatment for asthma in clinical practice in France.
Latry P; Pinet M; Labat A; Magand JP; Peter C; Robinson P; Martin-Latry K; Molimard M
Clin Ther; 2008; 30 Spec No():1058-68. PubMed ID: 18640480
[TBL] [Abstract][Full Text] [Related]
12. Medication use and disease control of asthmatic patients in Flanders: a cross-sectional community pharmacy study.
Mehuys E; Van Bortel L; Annemans L; Remon JP; Van Tongelen I; Van Ganse E; Laforest L; Chamba G; Brusselle G
Respir Med; 2006 Aug; 100(8):1407-14. PubMed ID: 16386885
[TBL] [Abstract][Full Text] [Related]
13. The sustainability of a community pharmacy intervention to improve the quality use of asthma medication.
Bereznicki B; Peterson G; Jackson S; Walters EH; Gee P
J Clin Pharm Ther; 2011 Apr; 36(2):144-51. PubMed ID: 21366642
[TBL] [Abstract][Full Text] [Related]
14. Management of asthma in patients supervised by primary care physicians or by specialists.
Laforest L; Van Ganse E; Devouassoux G; Chretin S; Osman L; Bauguil G; Pacheco Y; Chamba G
Eur Respir J; 2006 Jan; 27(1):42-50. PubMed ID: 16387934
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
16. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
17. What constitutes maintenance asthma care? The pediatrician's perspective.
Garbutt J; Bloomberg G; Banister C; Sterkel R; Epstein J; Bruns J; Swerczek L; Wells S
Ambul Pediatr; 2007; 7(4):308-12. PubMed ID: 17660103
[TBL] [Abstract][Full Text] [Related]
18. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
[TBL] [Abstract][Full Text] [Related]
19. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
20. Beliefs about medicines predict refill adherence to inhaled corticosteroids.
Menckeberg TT; Bouvy ML; Bracke M; Kaptein AA; Leufkens HG; Raaijmakers JA; Horne R
J Psychosom Res; 2008 Jan; 64(1):47-54. PubMed ID: 18157999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
